Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.verified

ELTX

Price:

$8.325

Market Cap:

$143.68M

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. The company's lead product candidate is ELI-002, an AMP therapeutic vaccine for the treatment of KRAS-driven cancers. It is also developing ELI-004, an AMP-modified CpG adjuvant, a component of ELI-002; ELI-007, a lymph node targeted AMP-peptide vaccine for mutant BRAF-driven cancers; ELI-008, a multivalent lymph node targeted AMP-peptide vaccine for mutant TP53-expressing cancers; ELI-005, a vaccine candidate for the prevention of COVID-19; ELI-011 for the treatment of hematological cancers; and ELI-012, a mKRAS TCR T ce...[Read more]

Industry

Biotechnology

IPO Date

2021-02-05

Stock Exchange

NASDAQ

Ticker

ELTX

The PE Ratio as of December 2025 (TTM) for Elicio Therapeutics, Inc. (ELTX) is -2.68

According to Elicio Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.68. This represents a change of 3.55% compared to the average of -2.59 of the last 4 quarters.

Elicio Therapeutics, Inc. (ELTX) Historical PE Ratio (quarterly & annually)

How has ELTX PE Ratio performed in the past?

The mean historical PE Ratio of Elicio Therapeutics, Inc. over the last ten years is -1.27. The current -2.68 PE Ratio has changed 21.02% with respect to the historical average. Over the past ten years (40 quarters), ELTX's PE Ratio was at its highest in in the December 2021 quarter at 0.30. The PE Ratio was at its lowest in in the September 2025 quarter at -4.53.

Quarterly (TTM)
Annual

Average

-1.27

Median

-0.87

Minimum

-3.92

Maximum

0.12

Elicio Therapeutics, Inc. (ELTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Elicio Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 351.46%

Maximum Annual PE Ratio = 0.12

Minimum Annual Increase = -1621.08%

Minimum Annual PE Ratio = -3.92

Quarterly (TTM)
Annual
YearPE RatioChange
2024-1.200.09%
2023-1.2085.10%
2022-0.65-9.33%
2021-0.71-76.63%
2020-3.06-21.97%
2019-3.92351.46%
2018-0.87-1621.08%
20130.06-51.39%

Elicio Therapeutics, Inc. (ELTX) Average PE Ratio

How has ELTX PE Ratio performed in the past?

The current PE Ratio of Elicio Therapeutics, Inc. (ELTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-1.01

5-year avg

-1.36

10-year avg

-1.27

Elicio Therapeutics, Inc. (ELTX) PE Ratio vs. Peers

How is ELTX’s PE Ratio compared to its peers?

Elicio Therapeutics, Inc.’s PE Ratio is less than Applied Therapeutics, Inc. (-1.84), less than Corbus Pharmaceuticals Holdings, Inc. (-2.26), less than Molecular Partners AG (-1.96), greater than Cardiff Oncology, Inc. (-2.86), less than Rani Therapeutics Holdings, Inc. (-1.93), greater than Milestone Pharmaceuticals Inc. (-5.53), less than PepGen Inc. (-1.79), less than Nkarta, Inc. (-1.25), less than Cassava Sciences, Inc. (-1.51), greater than Actuate Therapeutics Inc (-6.52),

Build a custom stock screener for Elicio Therapeutics, Inc. (ELTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Elicio Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Elicio Therapeutics, Inc. (ELTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Elicio Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Elicio Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Elicio Therapeutics, Inc. (ELTX)?

What is the highest PE Ratio for Elicio Therapeutics, Inc. (ELTX)?

What is the 3-year average PE Ratio for Elicio Therapeutics, Inc. (ELTX)?

What is the 5-year average PE Ratio for Elicio Therapeutics, Inc. (ELTX)?

How does the current PE Ratio for Elicio Therapeutics, Inc. (ELTX) compare to its historical average?